International Journal of Clinical Oncology

, Volume 19, Issue 3, pp 423–430 | Cite as

Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma

Review Article

Abstract

The primary treatment modality of oral cancer is generally determined according to the stage of the disease, with surgical treatment remaining the mainstay of multimodal treatment. When selecting the treatment, many factors are taken into consideration, and the treatment should be tailored individually to the patient’s needs and consider the quality of life as well as the survival of the patient. Early-stage disease is primarily managed with surgery or brachytherapy without functional morbidity, whereas for advanced-stage disease multidisciplinary treatment is recommended, not only for enhanced survival but also for improved quality of life. After resection of large primary tumors, reconstructive surgery is required. Free tissue transfer currently represents one of the most popular and reliable techniques for oral reconstruction. For cN0 neck, elective neck dissection is recommended when the risk of occult metastases is >20 %, when the neck is entered either for resection of the primary tumor or for reconstruction, or when the patient is unlikely to return for a close follow-up. Sentinel node biopsy is performed investigationally. Modified radical neck dissection is the gold standard for cN+ neck. For patients with multiple node metastases or extracapsular spread, postoperative radiotherapy or chemoradiotherapy is recommended, with the lymph nodes situated outside the confines of the radical neck dissection, such as the lingual and retropharyngeal nodes, receiving considerable attention. Targeted therapy for oral cancer is still a relatively new concept, and more studies are needed to confirm the clinical effectiveness of these drugs.

Keywords

Multidisciplinary treatment Postoperative chemoradiotherapy Quality of life 

Notes

Conflict of interest

There are no conflicts of interest to declare.

References

  1. 1.
    Ariyoshi Y, Shimahara M, Omura K et al (2008) Epidemiological study of malignant tumors in the oral and maxillofacial region: survey of member institutions of the Japanese Society of Oral and Maxillofacial Surgeons, 2002. Int J Clin Oncol 13:220–228PubMedCrossRefGoogle Scholar
  2. 2.
    McGuirt WF (1982) Panendoscopy as a screening examination for simultaneous primary tumors in head and neck cancer: a prospective sequential study and review of the literature. Laryngoscope 92:569–576PubMedCrossRefGoogle Scholar
  3. 3.
    Saikawa M, Ebihara S, Yoshizumi T et al (1991) Multiple primary cancers in patients with squamous cell carcinoma of the oral cavity. Jpn J Cancer Res 82:40–45PubMedCrossRefGoogle Scholar
  4. 4.
    Sutton DN, Brown JS, Rogers SN et al (2003) The prognostic implications of the surgical margin in the oral squamous cell carcinoma. Int J Oral Maxillofac Surg 32:30–34PubMedCrossRefGoogle Scholar
  5. 5.
    McMahon J, O’Brien CJ, Pathak I et al (2003) Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg 41:224–231PubMedCrossRefGoogle Scholar
  6. 6.
    Mistry RC, Qureshi SS, Kumaran C (2005) Post-resection mucosal margin shrinkage in oral cancer: quantification and significance. J Surg Oncol 91:131–133PubMedCrossRefGoogle Scholar
  7. 7.
    Meier JD, Oliver DA, Varvares MA (2005) Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey. Head Neck 27:952–958PubMedCrossRefGoogle Scholar
  8. 8.
    Kurita H, Kurashina K (1996) Vital staining with iodine solution in delineating the border of oral dysplastic lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:275–280PubMedCrossRefGoogle Scholar
  9. 9.
    Xiao T, Kurita H, Shimane T et al (2013) Vital staining with iodine solution in oral cancer: iodine infiltration, cell proliferation, and glucose transporter 1. Int J Clin Oncol 18:792–800PubMedCrossRefGoogle Scholar
  10. 10.
    Petruzzi M, Lucchese A, Baldoni E et al (2010) Use of Lugol’s iodine in oral cancer diagnosis: an overview. Oral Oncol 46:811–813PubMedCrossRefGoogle Scholar
  11. 11.
    Hidalgo DA, Disa JD, Cordeiro PG et al (1998) A review of 716 consecutive free flaps for oncologic surgical defects: refinements in donor site selection and technique. Plast Reconstr Surg 102:722–732PubMedGoogle Scholar
  12. 12.
    Sakuraba M, Miyamoto S, Kimata Y et al (2013) Recent advances in reconstructive surgery: head and neck reconstruction. Int J Clin Oncol 18:561–565PubMedCrossRefGoogle Scholar
  13. 13.
    Kudoh M (2010) Longitudinal assessment of articulatory and masticatory functions following glossectomy for tongue carcinoma. Kokubyo Gakkai Zasshi 77:27–34PubMedGoogle Scholar
  14. 14.
    Lam L, Samman N (2013) Speech and swallowing following tongue cancer surgery and free flap reconstruction—a systematic review. Oral Oncol 49:507–524PubMedCrossRefGoogle Scholar
  15. 15.
    Kimata Y, Sakuraba M, Hishinuma S et al (2003) Analysis of the relations between the shape of the reconstructed tongue and postoperative functions after subtotal or total glossectomy. Laryngoscope 113:905–909PubMedCrossRefGoogle Scholar
  16. 16.
    Yanai C, Kikutani T, Adachi M et al (2008) Functional outcome after total and subtotal glossectomy with free flap reconstruction. Head Neck 30:909–918PubMedCrossRefGoogle Scholar
  17. 17.
    Biller HF, Lawson W, Baek SM (1983) Total glossectomy. A technique of reconstruction eliminating laryngectomy. Arch Otolaryngol 109:69–73PubMedCrossRefGoogle Scholar
  18. 18.
    Fujimoto Y, Hasegawa Y, Yamada H et al (2007) Swallowing function following extensive resection of oral or oropharyngeal cancer with laryngeal suspension and cricopharyngeal myotomy. Laryngoscope 117:1343–1348PubMedCrossRefGoogle Scholar
  19. 19.
    McColl HA Jr, Horwood J (1978) ‘Localized’ carcinoma of the mobile tongue and floor of mouth—a lesion frequently misjudged and undertreated. J Surg Oncol 10:337–345PubMedCrossRefGoogle Scholar
  20. 20.
    Hicks WL Jr, Lorre TR, Garcia RI et al (1997) Squamous cell carcinoma of the floor of mouth: a 20-year review. Head Neck 19:400–405PubMedCrossRefGoogle Scholar
  21. 21.
    Boyd JB, Mulholland RS, Davidson J et al (1995) The free flap and plate in oromandibular reconstruction: long-term review and indications. Plast Reconstr Surg 95:1018–1028PubMedGoogle Scholar
  22. 22.
    Head C, Alam D, Sercarz JA et al (2003) Microvascular flap reconstruction of the mandible: a comparison of bone grafts and bridging plates for restoration of mandibular continuity. Otolaryngol Head Neck Surg 129:48–54PubMedCrossRefGoogle Scholar
  23. 23.
    Takushima A, Harii K, Asato H et al (2001) Mandibular reconstruction using microvascular free flap: a statistical analysis of 178 cases. Plast Reconstr Surg 108:1555–1563PubMedGoogle Scholar
  24. 24.
    Hao SP, Cheng MH (2004) Cancer of the buccal mucosa and retromolar trigone. Oper Tech Otolaryngol 15:239–251CrossRefGoogle Scholar
  25. 25.
    Ozkan O, Mardini S, Chen HC et al (2006) Repair of buccal defects with anterolateral thigh flaps. Microsurgery 26:182–189PubMedCrossRefGoogle Scholar
  26. 26.
    Liu WW, Yang AK, Ou YD (2011) The harvesting and insetting of a chimeric anterolateral thigh flap to reconstruct through and through cheek defects. Int J Oral Maxillofac Surg 40:1421–1423PubMedCrossRefGoogle Scholar
  27. 27.
    Mendenhall WM, Morris CG, Amdur RJ et al (2005) Retromolar trigone squamous cell carcinoma treated with radiotherapy alone or combined with surgery. Cancer 103:2320–2325PubMedCrossRefGoogle Scholar
  28. 28.
    Genden FM, Ferito A, Shaha AR et al (2003) Management of cancer of the retromolar trigone. Oral Oncol 39:633–637PubMedCrossRefGoogle Scholar
  29. 29.
    McGregor AD, MacDonald DG (1988) Routes of entry of squamous cell carcinoma to the mandible. Head Neck 10:294–301CrossRefGoogle Scholar
  30. 30.
    Totsuka Y, Usui Y, Tei K et al (1991) Mandibular involvement by squamous cell carcinoma of the lower alveolus. Analysis and comparative study of histologic and radiologic features. Head Neck 13:40–50PubMedCrossRefGoogle Scholar
  31. 31.
    Virag MM, Bunarević A, Aljinović N (1991) Recurrences of oral cancer due to discontinuous periosteal involvement. Am J Surg 162:388–392PubMedCrossRefGoogle Scholar
  32. 32.
    Fujibayashi T (2004) Level of mandibular canal (LMC) criteria of lower gingival carcinomas and mode of mandibulectomy according to LMC criteria and bone invasion pattern. J Jpn Soc Oral Tumors 16:35–48CrossRefGoogle Scholar
  33. 33.
    Totsuka Y, Usui Y, Tei K et al (1991) Results of surgical treatment for squamous carcinoma of the lower alveolus: segmental vs marginal resection. Head Neck 13:114–120PubMedCrossRefGoogle Scholar
  34. 34.
    Ord RA, Sarmadi M, Papadimitrou J (1997) A comparison of segmental and marginal bony resection for oral squamous cell carcinoma involving the mandible. J Oral Maxillofac Surg 55:470–477PubMedCrossRefGoogle Scholar
  35. 35.
    Politi M, Costa F, Robiony M et al (2000) Review of segmental and marginal resection of the mandible in patients with oral cancer. Acta Otolaryngol 120:569–579PubMedCrossRefGoogle Scholar
  36. 36.
    Wax MK, Bascom DA, Myers LL (2002) Marginal mandibulectomy vs segmental mandibulectomy, indication and controversies. Arch Otolaryngol Head Neck Surg 128:600–603PubMedCrossRefGoogle Scholar
  37. 37.
    Genden EM, Rinaldo A, Jacobson A et al (2005) Management of mandibular invasion: when is a marginal mandibulectomy appropriate? Oral Oncol 41:776–782PubMedCrossRefGoogle Scholar
  38. 38.
    O’Brien CJ, Adams JR, McNeil EB et al (2003) Influence of bone invasion and extent of mandibular resection on local control of cancers of the oral cavity and oropharynx. Int J Oral Maxillofac Surg 32:492–497PubMedCrossRefGoogle Scholar
  39. 39.
    Patel RS, Dirven R, Clark JR et al (2008) The prognostic impact of extent of bone invasion and extent of bone resection in oral carcinoma. Laryngoscope 118:780–785PubMedCrossRefGoogle Scholar
  40. 40.
    Swearingen AG, McGraw JP, Palumbo VD (1966) Roentgenographic pathologic correlation of carcinoma of the gingival involving the mandible. Am J Roentogenol 96:15–18CrossRefGoogle Scholar
  41. 41.
    Wong RJ, Keel SB, Glynn RJ et al (2000) Histological pattern of mandibular invasion by oral squamous cell carcinoma. Laryngoscope 110:65–72PubMedCrossRefGoogle Scholar
  42. 42.
    Nomura T, Shibahara T, Cui NH et al (2005) Patterns of mandibular invasion by gingival squamous cell carcinoma. J Oral Maxillofac Surg 63:1489–1493PubMedCrossRefGoogle Scholar
  43. 43.
    Tei K, Totsuka Y, Iizuka T et al (2004) Marginal resection for carcinoma of the mandibular alveolus and gingiva where radiologically detected bone defects do not extend beyond the mandibular canal. J Oral Maxillofac Surg 62:834–839PubMedCrossRefGoogle Scholar
  44. 44.
    Werning JW, Byers RM, Novas MA et al (2001) Preoperative assessment for and outcomes of mandibular conservation surgery. Head Neck 23:1024–1030PubMedCrossRefGoogle Scholar
  45. 45.
    Robbins KT, Clayman G, Levine PA et al (2002) Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology–Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 128:751–758PubMedCrossRefGoogle Scholar
  46. 46.
    Sheahan P, O’Keane C, Sheahan JN et al (2003) Predictors of survival in early oral cancer. Otolaryngol Head Neck Surg 129:571–576PubMedCrossRefGoogle Scholar
  47. 47.
    Veness MJ, Morgan GJ, Sathiyaseelan Y et al (2005) Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients? ANZ J Surg 75:101–105PubMedCrossRefGoogle Scholar
  48. 48.
    Mark Taylor S, Drover C, Maceachern R et al (2010) Is preoperative ultrasonography accurate in measuring tumor thickness and predicting the incidence of cervical metastasis in oral cancer? Oral Oncol 46:38–41PubMedCrossRefGoogle Scholar
  49. 49.
    Kurokawa H, Yamashita Y, Takeda S et al (2002) Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue. Head Neck 24:731–736PubMedCrossRefGoogle Scholar
  50. 50.
    Sparano A, Weinstein G, Chalian A et al (2004) Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg 131:472–476PubMedCrossRefGoogle Scholar
  51. 51.
    Lim SC, Zhang S, Ishii G et al (2004) Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res 10:166–172PubMedCrossRefGoogle Scholar
  52. 52.
    Chien CY, Su CY, Hwang CF et al (2006) High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis. J Surg Oncol 94:413–417PubMedCrossRefGoogle Scholar
  53. 53.
    Capote A, Escorial V, Muñoz-Guerra MF et al (2007) Elective neck dissection in early-stage oral squamous cell carcinoma. Does it influence recurrence and survival ? Head Neck 29:3–11PubMedCrossRefGoogle Scholar
  54. 54.
    Dias FL, Kligerman J, Matos de Sá G et al (2001) Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 125:23–29PubMedCrossRefGoogle Scholar
  55. 55.
    Keski-Santti H, Atula T, Törnwall J et al (2006) Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol 42:96–101PubMedCrossRefGoogle Scholar
  56. 56.
    Asakage T, Kishimoto S, Saikawa M et al (2005) The standardization of neck dissection for tongue carcinoma. Jpn Head Neck Cancer 31:536–540Google Scholar
  57. 57.
    Weiss M, Harrison LB, Isaacs RS (1994) Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 120:699–702PubMedCrossRefGoogle Scholar
  58. 58.
    Majoufre C, Faucher A, Laroche C et al (1999) Supraomohyoid neck dissection in cancer of the oral cavity. Am J Surg 178:73–77PubMedCrossRefGoogle Scholar
  59. 59.
    Yu S, Li J, Zhang W et al (2006) Efficacy of supraomohyoid neck dissection in patients with oral squamous cell carcinoma and negative neck. Am J Surg 191:94–99PubMedCrossRefGoogle Scholar
  60. 60.
    Byers RM, Weber RS, Andrews T et al (1997) Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck 19:14–19PubMedCrossRefGoogle Scholar
  61. 61.
    Dias FL, Lima RA, Kligerman J et al (2006) Relevance of skip metastases for squamous cell carcinoma of the oral tongue and the floor of the mouth. Otolaryngol Head Neck Surg 134:460–465PubMedCrossRefGoogle Scholar
  62. 62.
    Ferlito A, Silver CE, Rinaldo A (2009) Elective management of the neck in oral cavity squamous carcinoma: current concepts supported by prospective studies. Br J Oral Maxillofac Surg 47:5–9PubMedCrossRefGoogle Scholar
  63. 63.
    Terada A, Hasegawa Y, Yatabe Y et al (2011) Follow-up after intraoperative sentinel node biopsy of N0 neck oral cancer patients. Eur Arch Otorhinolaryngol 268:429–435PubMedCrossRefGoogle Scholar
  64. 64.
    Melkane AE, Mamelle G, Wycisk G et al (2012) Sentinel node biopsy in early oral squamous cell carcinomas: a 10-year experience. Laryngoscope 122:1782–1788PubMedCrossRefGoogle Scholar
  65. 65.
    Broglie MA, Haerle SK, Huber GF et al (2013) Occult metastases detected by sentinel node biopsy in patients with early oral and oropharyngeal squamous cell carcinomas: impact on survival. Head Neck 35:660–666PubMedCrossRefGoogle Scholar
  66. 66.
    O’Brien CJ, Urist MM, Maddox WA (1987) Modified radical neck dissection. Terminology, technique, and indications. Am J Surg 153:310–316PubMedCrossRefGoogle Scholar
  67. 67.
    Kowalski LP, Bagietto R, Lara JR et al (2000) Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck 22:207–214PubMedCrossRefGoogle Scholar
  68. 68.
    Shingaki S, Nomura T, Takada M et al (1999) The impact of extranodal spread of lymph node metastases in patients with oral cancer. Int J Oral Maxillofac Surg 28:279–284PubMedCrossRefGoogle Scholar
  69. 69.
    Cooper JS, Pajak TF, Forastiere AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944PubMedCrossRefGoogle Scholar
  70. 70.
    Bernier J, Domenge C, Ozsahin M et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952PubMedCrossRefGoogle Scholar
  71. 71.
    Ozeki S, Tashiro H, Okamoto M et al (1985) Metastasis to the lingual lymph node in carcinoma of the tongue. J Maxillofac Surg 13:277–281PubMedCrossRefGoogle Scholar
  72. 72.
    Ando M, Asai M, Asakage T et al (2009) Metastatic neck diseases beyond the limits of a neck dissection: attention to the ‘para-hyoid’ area in T1/2 oral tongue cancer. Jpn J Clin Oncol 39:231–236PubMedCrossRefGoogle Scholar
  73. 73.
    Tseng JR, Ho TY, Lin CY et al (2013) Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT. PLoS One 8(11):e79766PubMedCentralPubMedCrossRefGoogle Scholar
  74. 74.
    Gross ND, Ellingson TW, Wax MK et al (2004) Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130:169–173PubMedCrossRefGoogle Scholar
  75. 75.
    Umeda M, Shigeta T, Takahashi H et al (2009) Metastasis to the lateral retropharyngeal lymph node from squamous cell carcinoma of the oral cavity: report of three cases. Int J Oral Maxillofac Surg 38:1004–1008PubMedCrossRefGoogle Scholar
  76. 76.
    Hasegawa Y, Matsuura H (1994) Retropharyngeal node dissection in cancer of the oropharynx and hypopharynx. Head Neck 16:173–180PubMedCrossRefGoogle Scholar
  77. 77.
    Omura K, Shimada F, Takemiya S (1985) Dissection of parapharyngeal space in head and neck cancer. Auris Nasus Larynx 12(Suppl 2):S56–S60PubMedGoogle Scholar
  78. 78.
    Huang J, Barbera L, Brouwers M et al (2003) Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21:555–563PubMedCrossRefGoogle Scholar
  79. 79.
    Robbins KT, Kumar P, Regine WF et al (1997) Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys 38:263–271PubMedCrossRefGoogle Scholar
  80. 80.
    Furusaka T, Asakawa T, Tanaka A et al (2012) Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer. Acta Otolaryngol 132:1108–1114PubMedCrossRefGoogle Scholar
  81. 81.
    Tohnai I, Fuwa N, Hayashi Y et al (1998) New superselective intra-arterial infusion via superficial temporal artery for cancer of the tongue and tumour tissue platinum concentration after carboplatin (CBDCA) infusion. Oral Oncol 34:387–390PubMedCrossRefGoogle Scholar
  82. 82.
    Mitsudo K, Shigetomi T, Fujimoto Y et al (2011) Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer. Int J Radiat Oncol Biol Phys 79:1428–1435PubMedCrossRefGoogle Scholar
  83. 83.
    Chen IH, Chang JT, Liao CT et al (2003) Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis. Br J Cancer 89:681–686PubMedCentralPubMedCrossRefGoogle Scholar
  84. 84.
    Bonner JA, Harari PM, Giralt J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567–578PubMedCrossRefGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2014

Authors and Affiliations

  1. 1.Oral and Maxillofacial Surgery, Graduate SchoolTokyo Medical and Dental UniversityTokyoJapan

Personalised recommendations